163 related articles for article (PubMed ID: 8483427)
41. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
42. Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints.
Vartiainen J; Wahlström T; Nilsson CG
Maturitas; 1993 Sep; 17(2):129-37. PubMed ID: 8231904
[TBL] [Abstract][Full Text] [Related]
43. Vaginal ring an HT alternative.
Cothran MM; Engberg S
Nurse Pract; 2004 Jul; 29(7):54-5. PubMed ID: 15238860
[No Abstract] [Full Text] [Related]
44. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
45. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.
Santos I; Clissold S
Gynecol Endocrinol; 2010 Sep; 26(9):644-51. PubMed ID: 20374067
[TBL] [Abstract][Full Text] [Related]
46. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.
Eriksen PS; Rasmussen H
Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):137-44. PubMed ID: 1587379
[TBL] [Abstract][Full Text] [Related]
47. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
48. Safety and efficacy of micronized estradiol vaginal cream.
Gordon WE; Hermann HW; Hunter DC
South Med J; 1979 Oct; 72(10):1252-3, 1258. PubMed ID: 482979
[TBL] [Abstract][Full Text] [Related]
49. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
51. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
[TBL] [Abstract][Full Text] [Related]
52. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial.
Manonai J; Songchitsomboon S; Chanda K; Hong JH; Komindr S
Maturitas; 2006 May; 54(2):135-40. PubMed ID: 16297576
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
54. Urogenital aging: solutions in clinical practice.
Notelovitz M
Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S35-9. PubMed ID: 9386214
[TBL] [Abstract][Full Text] [Related]
55. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
Meaidi A; Goukasian I; Lidegaard O
Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
[TBL] [Abstract][Full Text] [Related]
56. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
[TBL] [Abstract][Full Text] [Related]
57. Local estrogen treatment in patients with urogenital symptoms.
Simunić V; Banović I; Ciglar S; Jeren L; Pavicić Baldani D; Sprem M
Int J Gynaecol Obstet; 2003 Aug; 82(2):187-97. PubMed ID: 12873780
[TBL] [Abstract][Full Text] [Related]
58. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
59. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
[TBL] [Abstract][Full Text] [Related]
60. Low-dose 17 beta-oestradiol during maintenance therapy--a pharmacokinetic and pharmacodynamic study.
Nilsson K; Heimer G
Maturitas; 1995 Jan; 21(1):33-8. PubMed ID: 7731381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]